Back
PubMatic, Inc. Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
27
PUBM
PubMatic, Inc.
Last Price:
$8.83
Seasonality Move:
6.51%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$767.87
Seasonality Move:
12.13%
Sell
27
PubMatic, Inc. (PUBM)
is a Sell
Is PubMatic, Inc. a Buy, Sell or Hold?
-
The current PubMatic, Inc. [PUBM] share price is $8.83. The Score for PUBM is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
PUBM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $767.96. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PUBM Stock Price Chart
What is PubMatic, Inc.'s stock price today?
-
The PubMatic, Inc. share price today is $8.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PUBM is experiencing slight selling pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $767.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PUBM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.68 | Buy |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | -520288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.82 - 9.22) | Sell |
| Bollinger Bands (100): | (7.92 - 9.7) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 142.35 | Buy |
| Relative Strength Index (14 RSI): | 64.22 | Buy |
| Chaikin Money Flow: | 1264020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (712.01 - 765.19) | Buy |
| Bollinger Bands (100): | (552.57 - 698.59) | Buy |
PUBM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9 | Sell |
| 20-day SMA: | 9 | Sell |
| 50-day SMA: | 8.72 | Buy |
| 200-day SMA: | 9.82 | Sell |
| 8-day EMA: | 4.72 | Buy |
| 20-day EMA: | 2.31 | Buy |
| 50-day EMA: | 1.01 | Buy |
| 200-day EMA: | 0.26 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 747.47 | Buy |
| 20-day SMA: | 745.1 | Buy |
| 50-day SMA: | 678.03 | Buy |
| 200-day SMA: | 600.91 | Buy |
| 8-day EMA: | 400.86 | Buy |
| 20-day EMA: | 196.11 | Buy |
| 50-day EMA: | 85.47 | Buy |
| 200-day EMA: | 22.33 | Buy |
PubMatic, Inc. Earnings Growth & PUBM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.07 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
PubMatic, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||